Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

4 results

Sort by

List item

Human medicine European public assessment report (EPAR): Zynteglo

Autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene, beta-Thalassemia
Date of authorisation: 29/05/2019, , , , , Revision: 5, Withdrawn, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Prepandrix

A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 14/05/2008, , Revision: 13, Withdrawn, Last updated: 23/02/2021
List item

Human medicine European public assessment report (EPAR): Lartruvo

Olaratumab, Sarcoma
Date of authorisation: 09/11/2016, , , , Revision: 3, Withdrawn, Last updated: 02/09/2019
List item

Human medicine European public assessment report (EPAR): Daklinza

daclatasvir dihydrochloride, Hepatitis C, Chronic
Date of authorisation: 22/08/2014, , Revision: 15, Withdrawn, Last updated: 30/08/2019